![Mark Finn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Finn
Direktor/Vorstandsmitglied bei
CALYXT, INC.
Profil
Mr. Mark Finn is an Advisory Board at Auven Therapeutics Management LLLP, a Chief Investment Officer at Virginia National Bank (Charlottesville) and a General Partner at Scientia Ventures LLC.
He is on the Board of Directors at Cibus Corp.
Mr. Finn was previously employed as a Trustee & Chair of the Investment Advisory Committee by Virginia Retirement Systems.
He received his undergraduate degree from the University of Virginia Darden School of Business and an MBA from Mason School of Business of The College of William & Mary.
Aktive Positionen von Mark Finn
| Unternehmen | Position | Beginn |
|---|---|---|
| CALYXT, INC. | Direktor/Vorstandsmitglied | - |
Scientia Ventures LLC
 Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Private Equity Investor | - |
Auven Therapeutics Management LLLP
 Auven Therapeutics Management LLLP Investment ManagersFinance Auven Therapeutics Management focuses on acquiring novel, life-saving and quality of life-enhancing products and accelerating the development of these products. They take ownership and control of the development of carefully selected clinical-stage therapeutic assets in order to build value around them to the point where they are attractive acquisition opportunities for established pharmaceutical and biotechnology companies. | Berater | - |
Virginia National Bank (Charlottesville)
 Virginia National Bank (Charlottesville) Major BanksFinance Operates as a national chartered bank | Chief Investment Officer | - |
Ehemalige bekannte Positionen von Mark Finn
| Unternehmen | Position | Ende |
|---|---|---|
Virginia Retirement Systems
 Virginia Retirement Systems Investment ManagersFinance VRS employs various strategies including Public Equities, Fixed Income, Short-Term Investments, Private Equity, Real Assets, Credit Strategies, and Strategic Opportunities. The firm maintains a long-term investment horizon and asset allocation policy for the management of fund assets. They invest with top-tier alternative investment managers (private investments and hedge funds) that consistently generate strong net returns. | Corporate Officer/Principal | - |
Ausbildung von Mark Finn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
42
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Virginia Retirement Systems
Virginia Retirement Systems Investment ManagersFinance VRS employs various strategies including Public Equities, Fixed Income, Short-Term Investments, Private Equity, Real Assets, Credit Strategies, and Strategic Opportunities. The firm maintains a long-term investment horizon and asset allocation policy for the management of fund assets. They invest with top-tier alternative investment managers (private investments and hedge funds) that consistently generate strong net returns. | Finance |
Cibus Corp.
 Cibus Corp. BiotechnologyHealth Technology Operates as an agricultural technology company that develops gene edited plant traits | Health Technology |
Virginia National Bank (Charlottesville)
Virginia National Bank (Charlottesville) Major BanksFinance Operates as a national chartered bank | Finance |
Auven Therapeutics Management LLLP
Auven Therapeutics Management LLLP Investment ManagersFinance Auven Therapeutics Management focuses on acquiring novel, life-saving and quality of life-enhancing products and accelerating the development of these products. They take ownership and control of the development of carefully selected clinical-stage therapeutic assets in order to build value around them to the point where they are attractive acquisition opportunities for established pharmaceutical and biotechnology companies. | Finance |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mason School of Business of The College of William & Mary
 Mason School of Business of The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scientia Ventures LLC
Scientia Ventures LLC Investment ManagersFinance Scientia Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of computational biology and chemistry, the digitization of medicine, and digital therapies as well as traditional drug development companies at the cutting edge of the life sciences. It participates in early stage transactions. | Finance |
